OM:SOBIBiotechs
Swedish Orphan Biovitrum (OM:SOBI) Stock Could Be 6.7% Undervalued After EHA2026 Data Update
Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after announcing a broad slate of clinical and real-world data presentations at the 2026 Congress of the European Hematology Association in Stockholm.
See our latest analysis for Swedish Orphan Biovitrum.
The latest EHA2026 data slate comes after a period of strong share price momentum for Swedish Orphan Biovitrum, with a 90 day share price return of 22.48% and a 1 year total shareholder return of 61.48%, suggesting investors are...